Skip to main content

CTTC Archives

FDA approves device based on Vanderbilt invention to ID parathyroid during head and neck surgeries

Dec. 17, 2018—Ten years after Professor of Biomedical Engineering Anita Mahadevan-Jansen discovered that parathyroid tissues glow under near-infrared light, the FDA has approved a device based on the technology for surgical use.

Read more


Ancora announces major funding awards to support Vanderbilt drug discovery research

Nov. 26, 2018—Ancora Innovation, LLC, the new collaboration between Vanderbilt and Deerfield Management established earlier this year, has completed its inaugural proposal review process and announced two projects selected for funding.

Read more


Business Valuation Seminar 2018 at Wond’ry Nov. 7

Oct. 19, 2018—Nashville-based valuation expert Glenn Perdue will lead a seminar on the valuation process of early-stage businesses on Wednesday, Nov. 7, at the Wond'ry.

Read more


CTTC to host session on funding opportunities for physicians, scientists developing new therapies

Oct. 7, 2018—Vanderbilt's Center for Technology Transfer and Commercialization will host a session on Oct. 16 with the Harrington Discovery Institute to explore funding opportunities for physicians and scientists who are developing new therapies.

Read more


Slides can help faculty with Ancora proposal submissions

May. 10, 2018—The Office of the Vice Provost for Research and the Center for Technology Transfer and Commercialization have posted informational slides for faculty preparing pre-proposal submissions in response to the inaugural Ancora request for proposals.

Read more


Ancora inaugural request for proposals announced

Apr. 20, 2018—The Office of the Vice Provost for Research and Deerfield Management announce the inaugural request for proposals for Ancora Innovation, LLC, with a due date of June 4. An RFP information session is scheduled from 2 to 3:30 p.m. Friday, April 27, at Sarratt Student Center, Room 325.

Read more


‘Collaborating with industry to advance basic science research’ topic of April 6 talk

Apr. 4, 2018—The Center for Technology Transfer and Commercialization's Alan Bentley will discuss emerging initiatives at Vanderbilt to engage industry more effectively, and a team from Deerfield Management will explain its collaborative approach to working with premier academic institutions to catalyze early stage therapeutic development.

Read more


Boehringer Ingelheim and Vanderbilt University expand partnership to develop novel treatment approaches for cancer

Mar. 14, 2018—New agreement will pursue therapies targeting MCL1 (myeloid cell leukemia 1), which is highly prevalent in many difficult-to-treat cancers.

Read more


Vanderbilt signs licensing, research agreements to develop new approach to schizophrenia treatment

Jan. 8, 2018—Under the terms of the licensing agreement, Lundbeck has exclusively licensed rights to compounds developed at Vanderbilt that act on a receptor in the brain that has been implicated in schizophrenia.

Read more


Vanderbilt is No. 10 in Thomson Reuters’ ‘World’s Most Innovative Universities’

Sep. 28, 2017—The ranking is based on a number of indicators, including patent filings and research paper citations.

Read more


Organ-on-a-chip mimics heart’s biomechanical properties

Feb. 22, 2017—Scientists at Vanderbilt University have created a three-dimensional organ-on-a-chip that can mimic the heart’s amazing biomechanical properties in order to study cardiac disease, develop heart drugs.

Read more


Vanderbilt ranked 20th among world’s 100 most innovative universities

Jan. 17, 2017—Vanderbilt ranked 20th in the second annual Reuters Top 100, which aims to identify the institutions doing the most to advance science, invent new technologies and help drive the global economy.

Read more


Upcoming Events

MORE EVENTS »